Lisa Banket
Cofounding Partner/Publisher
Taren Grom
Cofounding Partner/Editor-in-Chief
Heather Hummel
Project Coordinator
Dan Limbach
Producer, Webcast Network
Denise Myshko
Managing Editor
Kim Ribbink
Features Editor
Robin Robinson
Senior Editor
Marah Walsh
Cofounding Partner/New Business Development

PharmaVOICE Editors' Blog

Monday, December 29, 2014

Unveiling the New Artcraft Health Website

Artcraft Health recently updated its website, to better serve the interests of its clientele in the life sciences industry, including pharma, biotech, and medical device companies.

Here’s a quick company overview—They are an award-winning, full-service health education agency specializing in the creation and development of compelling solutions that are aligned with their clients’ strategic imperatives. They work with clients to develop strategies and tactics to overcome health literacy barriers and promote effective, innovative outcomes that drive results.

The website houses each strategic division, while showcasing Artcraft’s leadership team, innovative work, and solutions ranging from professional to motion media, awards, client experience, and testimonials. The website also gives an insight into their internal solutions and services, from the clinical trials division through mature brand extension. Their blog is filled with informative posts covering the latest trends in healthcare education such as patient engagement, risk-based contracts, and gamification.

“The Artcraft Health website showcases the talents and expertise of our team,” says Marc Sirockman, Executive Vice President and General Manager at Artcraft Health. “The look and feel depicts everything that the company stands for. It’s innovative, informative, and all-encompassing of our core principles and values.”

Experience the new website today.  Please visit

Monday, November 24, 2014

Pharma Social Media Strategy Guidebook - by Telerx

by Telerx

Social media presents new opportunities for patients to manage their health – empowering them to seek direct access to information about medical conditions, treatment options and patient communities. Are you prepared to support them?

Download the guidebook today to uncover a best practice approach to social participation and strategy development.


The increased adoption of social media is impacting every industry, but maybe none more than the healthcare industry. Patients and healthcare providers (HCPs) are looking to social media for information and support regarding their health and the health of their patients. Social media offers you an opportunity to interact with patients, caregivers and HCPs on topics for which you have unique and valuable insights. These interactions can improve outcomes, open new opportunities, and increase loyalty.

Monday, November 17, 2014

What is this new Patch Pump? Webinar Dec 2

Subcutaneous Delivery by Patch Pump – A New Route for Proven Parenterals

Tuesday – December 2, 2014 / 01:00 pm EST/10am PT – Free Attendance

Register now

Certificate of Attendance provided on request

Traditional delivery of parenteral drugs comes with an associated burden of cost, discomfort and inconvenience. Through the conversion of iv therapy to subcutaneous drug administration, made possible by novel patch pump technology, a new paradigm of "anytime, anywhere" drug delivery, has emerged. Drs. Muntendam, Pitt and Nguyen will introduce the enabling technology and the opportunities it presents to improve heart failure outcomes and outpatient parenteral antibiotic therapy (OPAT) treatment alternatives.

Key Take Aways:

  • Unique pump technology enables convenient and comfortable subcutaneous administration of parenteral drug by patient or caregiver.
  • Anytime, anywhere administration of parenteral drugs improves medical outcomes and reduces the burden to patient and payor.
  • Subcutaneous delivery of furosemide introduces new heart failure treatment options that reduce the reliance on inpatient and emergency room care.
  • Subcutaneous delivery of antibiotics enables effective antibiotic therapy without the need of PICC lines or infusion services.

Who Should Attend:

Managers and above in...
  • Infectious disease drug research and development
  • Cardiovascular drug and device research and development
  • Business development
  • Strategy
  • Medical Directors of health plans, hospitals, accountable care organizations, large family practices
  • Pharma Directors

Tuesday, November 11, 2014

OnDemand Webinar: Handling Missing Data in Analgesic Clinical Trials

Handling Missing Data in Analgesic Clinical Trials; Dropouts, Regulatory Strategies and Practical Implications

View the recorded webinar today
Speaker: Neil Singla, MD, Owner, Managing Member, Lotus Clinical Research

When it comes to subject dropouts, an ounce of prevention is worth a pound of cure. Subject and study staff education can reduce dropout rates. The lecture will focus on educational paradigms designed to reduce dropouts and their efficacy. Regardless of technique, dropouts cannot be eliminated. When dropouts occur, they need to be statistically accounted for utilizing accepted imputation methods. In the recently released FDA draft analgesic guidance, a significant amount discussion was devoted to the appropriate statistical handling of missing data. Dr. Singla will provide a primer on accepted imputation techniques for acute and chronic analgesic studies.

View OnDemand:

Friday, October 17, 2014

OnDemand Available: 10 Killer Applications for Digital Signatures in the Life Sciences Enterprise

Originally Recorded:
Wednesday – October 1, 2014 / 01:00 pm EST/10am PT – Free Attendance

(if you registered previously, use the same email address)

Includes live polls and a Q & A session.


Life sciences enterprises of all sizes are using digital signatures in a variety of ways across their business operation. They’re using this technology with their core quality management systems (QMS) and electronic document management systems (EDMS), as well as within various departments such as FDA-regulated clinical operations, manufacturing, field sales and service, research and discovery, and in non-FDA regulated back office applications.

Join us as we take a closer look at each of the 10 killer applications for digital signatures within a life sciences enterprise and uncover the tangible benefits that thousands of these enterprises are already enjoying. We’ll explore a number of real-world use cases involving these applications. Whether you’ve already deployed digital signatures within some of your departments or you’re still at the consideration stage, this webinar will be worth your while.

Topics include:
  • Defining standard digital signatures and their global acceptance in regulated applications
  • Considerations in using digital signatures for closed system applications throughout an enterprise for corporate governance
  • Strategies for deploying digital signatures in open systems for the front and middle office: collaboration and secure document exchange

Key Takeaways Include:
  • Discover new ways digital signatures can be used in the life sciences enterprise
  • Discover the value of digital signature automation for specific business processes
  • Learn the unique considerations for digital signatures in both closed and open systems from end-user case studies

Who Should View:
  • QA & Compliance
  • IT
  • COO
  • CIO
  • Department heads within: clinical operations, manufacturing, product management and project management
(if you registered previously, use the same email address)

Thursday, October 9, 2014

Key Takeaways from BigDiP (Big Data in Pharma)

Now that BigDip is over, it’s time to share some of the key insights shared during the conference. Some of the top thought leaders in the industry shared their insights with the attendees. If you attended, please add your takeaways in the comments below. If you were not able to attend, enjoy this recap and feel free to participate in the discussion as well.

* * * * * * * * * * * * * * *
  • Review current publications concerning your products or drugs in development to understand how comparative groups are being assigned today.
  • List any gaps that may exist in current research that could be addressed via observational data research provided the right data elements are collected.
  • Consider the value of closing these gaps via a registry environment only if the right data are not collected at the right times in the right patients for the right products.
 -          Billy Franks - Astellas

* * * * * * * * * * * * * * *

Complex Business Problems Drive Analytics Innovation.  Enable Disruptive Information by following these three principles:

  • Shared: The biggest difference in practical analytics may not be in how we analyze or interpret results but rather how that information is shared and consumed by all of us. 
  • Enabled:  Data/analytic portals and interactive analytic tools available to business leaders, analysts and scientists alike. 
  • Transparent: Information isn’t sequestered in static reports/memos and data isn’t hidden in disjointed data warehouses but rather is open and accessible to everyone.
 -          Christian Nimsch - SAS

* * * * * * * * * * * * * * *
  • Get Parallel - The difference between a lot of data and big data is parallel processing. Via Netezza, sharded SQL, Hadoop, Apache Spark, etc. If you are not yet in an environment where you can do parallel processing, you will soon run out of capacity.
  • Get to the Decision - If you can apply your analytics where you make the most decisions, you will generate the most value.
 - Greg Hayworth, Humana

* * * * * * * * * * * * * * *
  • In healthcare analytics a focus on causal conclusion is key.
  • Maximize the use of the longitudinal data structure healthcare records provide.
  • Three keys that will unlock the potential of healthcare database networks: size, depth, and speed.

 - Sebastian Schneeweiss – Harvard Medical School
* * * * * * * * * * * * * * *
  • Evaluate how quickly you are getting answers to critical questions.
  • Look at the bottlenecks in data processing and ask how well your system can scale if data volumes go up by a factor of ten or 100.
  • Honestly assess what the total cost of your system and its upkeep are, and ask if it has become unwieldy.
 -          Brian Bradbury - Amgen

 * * * * ** * * * * * * * * * * * * * *
  • Think of patient data as the new resource that will power drug discovery in the next decade. Are your systems ready?
  • Everyone should at least have pilots on how to manage large patient data. Genomic datasets are expected to grow beyond 100,000 patients, but current systems are not ready to handle even a few thousand patients.
  • Push the edge on data analytics and facilitate the combination of knowledge across disciplines (chemistry, biology, genetics, statistics etc.).
 -          Francesca Milletti - Roche

* * * * * * * * * * * * * * *
  • No development of any RWE BIG DATA platform is complete without the ability to provide an end- to -end view of the patient journey.
  • Think about, conceptualize and address “confounding by indication” & “ selection bias” every time real world BIG Data platforms are being developed and analyzed.
  • BIG Data stacking in R&D spans different methodologies that need to be coordinated simultaneously for any reliable analytic exercise.
 -          Usman Iqbal - AstraZeneca

* * * * * * * * * * * * * * *
  • Decide beforehand what are the questions that you plan to ask of the data. This will determine how you should store your data as the performance of the storage schema is impacted by the users queries.
  • Context is crucial - in many cases a single sensor may not suffice. Use multiple sensors to complete the picture
  • Data is dirty and outliers may skew your results. Ensure that you have a set of rules in place that will enable you to differentiate between "good" and "bad" data.
 -          Yadid Ayzenberg - MIT

* * * * * * * * * * * * * * *
  • To assure meaningful patient centered outcomes, plan for patient input through all stages of measures development, including concept elicitation, determination of item language and relevance, and testing.
  • Consider differences in patient preferences in the design and logistics of clinical trials based on condition, severity, demographics, and other patient level variables.
  • The potential utility of wearables is promising but requires a carefully considered engagement experience to enhance collection of meaningful data.
 -          Emil Chiauzzi – Patients Like Me

Wednesday, September 17, 2014

New White Paper - Proactive Pharmacovigilance: A New Model for the 21st Century

by Sciformix

21st century technologies will create significant opportunities and challenges for all health care stakeholders. Pharmacovigilance too is in transition, with new sources of medical information and methods for its analysis that will transform today's largely reactive system into proactive benefit-risk management for all medication users.

Key topics:
  • Why do we need a new PV model?
  • What might effective PV look like in 2038?
  • What are some new data sources?
  • How can I improve clinical decision making?
  • How do we achieve broad accessibility of appropriate information?
  • What are the cost-benefit considerations?

Download now

PharmaVOICE Webcast Network
provided by Sciformix

Wednesday, September 10, 2014

BigDip (Big Data in Pharma) Starts 9/16

SAS attends and presents at conference

Join SAS for two big events on Big Data

Workshop: Seeing is Believing: Data Visualization for Drug Development and Life Sciences Commercial Operations
9/16 9:00m PT

Session: Analytics Provide the Cure for Big Data Overload
9/18 9:30am PT

Hope to see you there!

Monday, September 8, 2014

White Paper: The Link Between Your Cold Chain and Your Bottom Line

White Paper

Specialty Solutions
3PL Services

One of the most critical, yet overlooked, aspects of product success is safe, successful distribution. And for a growing number of pharmaceuticals and biologics, that involves refrigerated, or cold chain, distribution. A problem with your cold chain can quickly become a problem with your bottom line. In this white paper, you'll learn why the cold chain is so vital for healthcare, as well as the risks and costs of improper shipping, the need for accurate documentation, and methods for protecting your products.

Download Now

Provided by: Cardinal Health

Tuesday, September 2, 2014

White Paper: Tips for Content That Drives Qualified Web Traffic for Healthcare Marketers

The socialization of the internet has made writing for and reaching a targeted audience not just possible, but necessary. While in the past you may have been successful with taking a broad approach to reaching patients and prospective clients, today users’ desires for more specific targeting and personalization require a more laser-like focus.

Effective web content is the new “Holy Grail” in internet marketing. But knowing this and producing it are two different things. Download the white paper to find out more.

Download now